Contact This Study Your name* First Your email* Your phone numberYour contact information will be sent to a team atYour contact information will be sent to a team at Your information will be kept confidential and will never be sold or shared with outside vendors.Study TitleA Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy (IgAN)HiddenStudy Email HiddenStudy Marketing TitleVisionaryHiddenSite NameJohn Hunter HospitalHiddenSite LocationNew South Wales, Australia.HiddenUser Role Sign up to get NephCure’s latest updates. SIGN UP Email(Required) PhoneThis field is for validation purposes and should be left unchanged.